US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 128.580
  • +0.010+0.01%
Close Feb 25 16:00 ET
  • 129.380
  • +0.800+0.62%
Post 20:01 ET
13.67BMarket Cap-178.58P/E (TTM)

Intra-Cellular Therapies Key Stats

Intra-Cellular Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 222.788M--
--2025/Q1-- / 205.078M--
--2024/Q4199.223M / 193.286M--
Oct 30, 20242024/Q3175.375M / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 222.788M--
--2025/Q1-- / 205.078M--
--2024/Q4199.223M / 193.286M--
Oct 30, 20242024/Q3175.375M / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--

Unlock Free Earnings Estimates

Intra-Cellular Therapies Earnings Reports

Read more

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More